Why Is Gain Therapeutics (GANX) Stock Down 25% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Gain Therapeutics stock is down on Friday after the company priced an $11 million public offering for roughly 7 million shares of GANX.

The post Why Is Gain Therapeutics (GANX) Stock Down 25% Today? appeared first on InvestorPlace.

More From InvestorPlace

• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
• Legendary Investor Predicts: “Forget A.I. THIS Technology Is the Future”